CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended September 30,
2007 2006
Net revenues:
Product revenue $6,833,350 $6,543,586
Other revenue $59,921 624,574
Revenues, net 6,893,271 7,168,160
Costs and expenses:
Cost of goods sold $3,922,586 3,630,380
Research and development $923,361 713,605
Marketing, general and
administrative $2,939,908 3,555,900
Total costs and expenses 7,785,855 7,899,885
Loss from operations (892,584) (731,725)
Other (expense) and income:
Equity in Ocular Telehealth
Management, LLC (34,111) (18,543)
Interest income 101,697 45,436
Interest expense (3,793) (9,285)
Total other income 63,793 17,608
Net (loss) before taxes (828,791) (714,117)
Provision for income taxes 0 0
Net (loss) $(828,791) $(714,117)
Basic net (loss) per share $(0.13) $(0.11)
Diluted net (loss) per share $(0.13) $(0.11)
Weighted average shares - basic 6,388,086 6,344,657
Weighted average shares - diluted 6,388,086 6,344,657
SELECTED BALANCE SHEET DATA:
September 30, June 30,
'/>"/>
| SOURCE Escalon Medical Corp. Copyright©2007 PR Newswire. All rights reserved |